As of June 2026, 3 paid clinical trials are recruiting for Non-small cell lung cancer (NSCLC) in Puyallup, Washington. Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Puyallup has approximately 31 recruiting research studies across a wide range of therapeutic areas. Washington hosts Fred Hutchinson Cancer Center, UW Medicine, and Seattle Children's — widely recognized for leadership in bone marrow transplantation, immunotherapy, and infectious disease research.
Researchers run research studies in Puyallup, WA at 17 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MultiCare Good Samaritan Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Elevated CA15-3 or CEA or CA27-29 | 8 |
| Northwest Medical Specialties, PLLC | Breast Neoplasms, Cancer of the Prostate, Carcinoma, Ductal, Breast | 4 |
| Northwest Medical Specialties | Advanced Solid Tumors, Breast Cancer, HER2-positive Breast Cancer | 2 |
| GSK Investigational Site | Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 1 |
| Mary Bridge Children's Therapy Unit - Research & Movement Lab | Adolescent, Pediatric ALL | 1 |
| MultiCare Ins Research Innovation | Lipoprotein Disorder | 1 |
| MultiCare Institute for Research Innovation | Right Ventricular (RV) Dysfunction | 1 |
| MultiCare Institute for Research and Innovation | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| MultiCare Regional Cancer Center | Metastatic Non-small Cell Lung Cancer | 1 |
| MultiCare Regional Cancer Center - Tacoma | Triple Negative Breast Cancer | 1 |
| Multicare Health Systems-Pulse Heart | Paroxysmal Atrial Fibrillation | 1 |
| Northwest Medical Specialities | Breast Cancer, Melanoma, Non-small Cell Lung Cancer | 1 |
| Northwest Medical Specialties - Puyallup Medical Oncology | Patients With Non-Small Cell Lung Cancer | 1 |
| Northwest Medical Specialties, PPLC | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 1 |
| Pulse Heart Institute | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| Tacoma/Valley Radiation Oncology Centers-Puyallup | Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain | 1 |
| USA09-0 | Solid Tumors | 1 |
Recruiting trials in Puyallup grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Washington are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Studies in Washington must also comply with the My Health My Data Act, which adds consumer-health-data protections on top of federal HIPAA requirements.
Hipa.ai aggregates every recruiting study in Puyallup from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 31 recruiting clinical trials in Puyallup, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Puyallup compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Puyallup include Breast Cancer (3), Multiple Myeloma (2), Adolescent (1), Advanced Solid Tumors (1), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Puyallup on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Puyallup include MultiCare Good Samaritan Hospital, Northwest Medical Specialties, PLLC, Northwest Medical Specialties, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Puyallup are Cancer & tumors (20), Cardiovascular (5), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.